Marker Therapeutics, Inc.

MRKR

$0.93

Name : Marker Therapeutics, Inc.

Sector : Healthcare

Industry: Biotechnology

Mark. Cap: $15,511,010.00

EPSttm : -0.42

Marker Therapeutics, Inc.

$0.93

2.08%

$0.02

MRKR — Price & Float Short

—— Fair value ★ EPS beat ★ EPS miss —— Target Price

Float Short %

1.3

Margin Of Safety %

Put/Call OI Ratio

EPS Next Q Diff

-0.08

EPS Last/This Y

0.23

EPS This/Next Y

0.04

Price

0.95

Target Price

7.87

Analyst Recom

Performance Q

-14.41

Upside

-756.8%

Beta

1.62

Ticker: MRKR

22 items of 1

Date	Symbol	Latest	P/C OI	P/C Vol	Total OI
2026-10-13	MRKR	0.9226	N/A	N/A	0
2026-10-14	MRKR	0.9	N/A	N/A	0
2026-10-15	MRKR	0.92	N/A	N/A	0
2026-10-16	MRKR	1.05	N/A	N/A	0
2026-10-19	MRKR	1.17	N/A	N/A	0
2026-10-20	MRKR	1.17	N/A	N/A	0
2026-10-21	MRKR	1.14	N/A	N/A	0
2026-10-22	MRKR	1.08	N/A	N/A	0
2026-10-23	MRKR	0.9748	N/A	N/A	0
2026-10-26	MRKR	0.9011	N/A	N/A	0
2026-10-27	MRKR	0.95	N/A	N/A	0
2026-10-28	MRKR	1.02	N/A	N/A	0
2026-10-29	MRKR	1.02	N/A	N/A	0
2026-10-30	MRKR	0.995	N/A	N/A	0
2026-11-02	MRKR	0.9057	N/A	N/A	0
2026-11-03	MRKR	0.9886	N/A	N/A	0
2026-11-04	MRKR	1.03	N/A	N/A	0
2026-11-05	MRKR	0.8954	N/A	N/A	0
2026-11-06	MRKR	0.9169	N/A	N/A	0
2026-11-09	MRKR	1.02	N/A	N/A	0
2026-11-10	MRKR	0.9604	N/A	N/A	0
2026-11-11	MRKR	0.9501	N/A	N/A	0
Date	Symbol	Latest	P/C OI	P/C Vol	Total OI

22 items 1 of 1

22 items of 1

Date	Ticker	Price	Current Quarter Growth Estimate	EBIT Estimation	Average EPS Estimate Current Year
2026-10-13	MRKR	0.92	-16.7	-	-0.56
2026-10-14	MRKR	0.89	-16.7	-	-0.56
2026-10-15	MRKR	0.92	-16.7	-	-0.56
2026-10-16	MRKR	1.04	-16.7	-	-0.56
2026-10-19	MRKR	1.20	-16.7	-	-0.56
2026-10-20	MRKR	1.20	-16.7	-	-0.56
2026-10-21	MRKR	1.17	-16.7	-	-0.56
2026-10-22	MRKR	1.06	-16.7	-	-0.56
2026-10-23	MRKR	0.96	-16.7	-	-0.56
2026-10-26	MRKR	0.91	-16.7	-	-0.56
2026-10-27	MRKR	0.95	-16.7	-	-0.56
2026-10-28	MRKR	1.00	-16.7	-	-0.56
2026-10-29	MRKR	0.98	-16.7	-	-0.56
2026-10-30	MRKR	0.97	-16.7	-	-0.56
2026-11-02	MRKR	0.90	-16.7	-	-0.56
2026-11-03	MRKR	0.99	-16.7	-	-0.56
2026-11-04	MRKR	1.01	-16.7	-	-0.56
2026-11-05	MRKR	0.90	-16.7	-	-0.56
2026-11-06	MRKR	0.92	-16.7	-	-0.56
2026-11-09	MRKR	1.00	-16.7	-	-0.56
2026-11-10	MRKR	0.96	-16.7	-	-0.56
2026-11-11	MRKR	0.95	-16.7	-	-0.56
Date	Ticker	Price	Current Quarter Growth Estimate	EBIT Estimation	Average EPS Estimate Current Year

22 items 1 of 1

21 items of 1

Date	Ticker	Insider Transactions	Institutional Transactions	Float Short
2026-10-13	MRKR	0.00	0.60	1.25
2026-10-14	MRKR	0.00	0.60	1.25
2026-10-15	MRKR	0.00	0.60	1.25
2026-10-16	MRKR	0.00	0.60	1.25
2026-10-19	MRKR	0.00	0.60	1.25
2026-10-20	MRKR	0.00	0.60	1.25
2026-10-21	MRKR	0.00	0.60	1.25
2026-10-22	MRKR	0.00	0.60	1.25
2026-10-23	MRKR	0.00	0.60	1.25
2026-10-26	MRKR	0.00	-0.01	1.25
2026-10-27	MRKR	0.00	-0.01	0.81
2026-10-28	MRKR	0.00	-0.01	0.81
2026-10-29	MRKR	0.00	-0.01	0.81
2026-10-30	MRKR	0.00	-0.01	0.81
2026-11-02	MRKR	0.00	-0.01	0.81
2026-11-03	MRKR	0.00	-0.01	0.81
2026-11-05	MRKR	0.00	-0.01	0.81
2026-11-06	MRKR	0.00	-0.01	0.81
2026-11-09	MRKR	0.00	-0.03	0.81
2026-11-10	MRKR	0.00	-0.03	0.81
2026-11-11	MRKR	0.00	-0.03	1.30
Date	Ticker	Insider Transactions	Institutional Transactions	Float Short

21 items 1 of 1

Last Quarter Act. EPS

-0.09

Avg. EPS Est. Current Quarter

-0.14

Avg. EPS Est. Next Quarter

-0.17

Insider Transactions

Institutional Transactions

-0.03

Beta

1.62

Average Sales Estimate Current Quarter

Average Sales Estimate Next Quarter

Fair Value

Quality Score

Growth Score

Sentiment Score

Actual DrawDown %

93.7

Max Drawdown 5-Year %

-95.2

Target Price

7.87

P/E

Forward P/E

PEG

P/S

6.77

P/B

1.3

P/Free Cash Flow

EPS

-0.48

Average EPS Est. Cur. Y

-0.56

EPS Next Y. (Est.)

-0.53

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

-372.69

Relative Volume

0.24

Return on Equity vs Sector %

-98

Return on Equity vs Industry %

-78.4

EPS 1 7Days Diff

EPS 1 30Days Diff

EBIT Estimation

◆ MRKR Healthcare

$0.95

📉

Swing / Pullback

Buy the dip on strong trends

N/A

WEAK

Trend

0/20

Pullback

17/25

Volume

11/15

Valuation

12/20

TP/AR

2/10

Options

0/10

RSI

Range 1M

21.1%

Sup Dist

2.9%

🚀

Momentum Growth

Ride accelerating trends

N/A

WEAK

Momentum

0/25

Growth

15/30

Estimates

0/20

Inst/Vol

1/15

Options

0/10

EPS Yr

24.9%

EPS NY

-47.8%

52W%

5.3%

💎

Long-Term Value

Quality companies, undervalued

N/A

WEAK

🟢 BUY +728.4% upside

Quality

2/30

Valuation

16/30

Growth

11/25

Stability

6/10

LT Trend

1/5

Upside

+728.4%

Quality

MRKR — P/E HistoricalBiotechnology

Marker Therapeutics, Inc.

Sector: Healthcare

Industry: Biotechnology

Employees: 5

Marker Therapeutics, Inc., a clinical-stage immuno-oncology company, develops and commercializes T cell-based immunotherapies for the treatment of hematological malignancies and solid tumor indications in the United States. The company's multi antigen recognizing (MAR)-T cell therapy technology is based on the selective expansion of non-engineered tumor-specific T cells that recognize tumor-associated antigens and kill tumor cells expressing those targets. It develops MT-601, which is in Phase 1 trials for the treatment of lymphoma and pancreatic cancer; and MT-401-OTS, which is in a Phase 1 trial for the treatment of acute myeloid leukemia and myelodysplastic syndromes. The company was formerly known as TapImmune, Inc. and changed its name to Marker Therapeutics, Inc. in October 2018. Marker Therapeutics, Inc. was founded in 1999 and is headquartered in Houston, Texas.

MRKR

Latest News

—

Caricamento notizie per MRKR…

stock quote shares MRKR – Marker Therapeutics Inc Stock Price stock today

news today MRKR – Marker Therapeutics Inc stock forecast ,stock prediction 2023 2024 2025

marketwatch MRKR – Marker Therapeutics Inc yahoo finance google finance

stock history MRKR – Marker Therapeutics Inc invest stock market

stock prices MRKR premarket after hours

ticker MRKR fair value insiders trading

Float Short %

Margin Of Safety %

Put/Call OI Ratio

EPS Next Q Diff

EPS Last/This Y

EPS This/Next Y

Price

Target Price

Analyst Recom

Performance Q

Upside

Beta

Ticker: MRKR

Last Quarter Act. EPS​

Avg. EPS Est. Current Quarter

Avg. EPS Est. Next Quarter

Insider Transactions

Institutional Transactions

Beta

Average Sales Estimate Current Quarter

Average Sales Estimate Next Quarter

Fair Value

Quality Score

Growth Score

Sentiment Score

Actual DrawDown %

Max Drawdown 5-Year %

Target Price

P/E

Forward P/E

PEG

P/S

P/B

P/Free Cash Flow

EPS

Average EPS Est. Cur. Y​

EPS Next Y. (Est.)

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

Relative Volume

Return on Equity vs Sector %

Return on Equity vs Industry %

EPS 1 7Days Diff

EPS 1 30Days Diff

EBIT Estimation

Latest News

Last Quarter Act. EPS

Average EPS Est. Cur. Y